A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/01 (2006.01) A61K 31/045 (2006.01) A61K 31/327 (2006.01) A61K 33/40 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2566180
A pharmaceutical formulation and its use. The pharmaceutical formulation contains peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an oxygen-containing oxidizing agent, Su has ozone; a penetrating solvent, such as dimethylsulfoxide (~DMSO~); a dye containing a chelated metal, such as hematoporphyrin; and an aromatic redox compound, such as benzoquinone. The pharmaceutical formulation is used to effectively treat patients affected with cancer, such as lymphoma.
L'invention concerne une formulation pharmaceutique et son utilisation. La formulation pharmaceutique contient une espèce peroxydique ou des produits de réaction résultant de l'oxydation d'un alcène, tel que le géraniol, par un agent d'oxydation oxygéné, tel que l'ozone; un solvant de pénétration, tel que le diméthylsulfoxyde (DMSO); un colorant contenant un métal chélaté, tel que l'hématoporphyrine; et un composé redox aromatique, tel que la benzoquinone. Cette formulation pharmaceutique est utilisée pour traiter efficacement des patients atteints d'un cancer, tel que le lymphome.
Hofmann Robert F.
Kirby Eades Gale Baker
Torquin Llc
LandOfFree
Use of targeted oxidative therapeutic formulation in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of targeted oxidative therapeutic formulation in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of targeted oxidative therapeutic formulation in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1403615